{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:48:52Z","timestamp":1778629732676,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1124\/jpet.105.094367","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T04:48:32Z","timestamp":1137646112000},"page":"1328-1334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Growth Hormone Determines Sexual Dimorphism of Hepatic Cytochrome P450 3A4 Expression in Transgenic Mice"],"prefix":"10.1016","volume":"316","author":[{"given":"Connie","family":"Cheung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-Ming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristopher W.","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda G.","family":"Byrd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lionel","family":"Feigenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Waxman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.105.094367_bib1","doi-asserted-by":"crossref","unstructured":"Ahluwalia A, Clodfelter KH, and Waxman DJ (2004) Sexual dimorphism of rat liver gene expression: regulatory role of growth hormone revealed by deoxyribonucleic acid microarray analysis. Mol Endocrinol 18: 747\u2013760.","DOI":"10.1210\/me.2003-0138"},{"key":"10.1124\/jpet.105.094367_bib2","doi-asserted-by":"crossref","unstructured":"Cheung C, Yu AM, Ward JM, Krausz KW, Akiyama TE, Feigenbaum L, and Gonzalez FJ (2005) The cyp2e1-humanized transgenic mouse: role of cyp2e1 in acetaminophen hepatotoxicity. Drug Metab Dispos 33: 449\u2013457.","DOI":"10.1124\/dmd.104.002402"},{"key":"10.1124\/jpet.105.094367_bib3","doi-asserted-by":"crossref","unstructured":"Cummings DE and Merriam GR (2003) Growth hormone therapy in adults. Annu Rev Med 54: 513\u2013533.","DOI":"10.1146\/annurev.med.54.101601.152147"},{"key":"10.1124\/jpet.105.094367_bib4","doi-asserted-by":"crossref","unstructured":"Galteau MM and Shamsa F (2003) Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals. Eur J Clin Pharmacol 59: 713\u2013733.","DOI":"10.1007\/s00228-003-0690-3"},{"key":"10.1124\/jpet.105.094367_bib5","doi-asserted-by":"crossref","unstructured":"Gandhi M, Aweeka F, Greenblatt RM, and Blaschke TF (2004) Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol 44: 499\u2013523.","DOI":"10.1146\/annurev.pharmtox.44.101802.121453"},{"key":"10.1124\/jpet.105.094367_bib6","doi-asserted-by":"crossref","unstructured":"Gelboin HV, Krausz KW, Goldfarb I, Buters JT, Yang SK, Gonzalez FJ, Korzekwa KR, and Shou M (1995) Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3\/4. Biochem Pharmacol 50: 1841\u20131850.","DOI":"10.1016\/0006-2952(95)02077-2"},{"key":"10.1124\/jpet.105.094367_bib7","doi-asserted-by":"crossref","unstructured":"Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, Deglmann CJ, Burk O, Buntefuss D, Escher S, et al. (2001) Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics 11: 111\u2013121.","DOI":"10.1097\/00008571-200103000-00002"},{"key":"10.1124\/jpet.105.094367_bib8","doi-asserted-by":"crossref","unstructured":"George J, Byth K, and Farrell GC (1995) Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver. Biochem Pharmacol 50: 727\u2013730.","DOI":"10.1016\/0006-2952(95)00192-3"},{"key":"10.1124\/jpet.105.094367_bib9","doi-asserted-by":"crossref","unstructured":"Gonzalez FJ (2003) Role of gene knockout and transgenic mice in the study of xenobiotic metabolism. Drug Metab Rev 35: 319\u2013335.","DOI":"10.1081\/DMR-120026496"},{"key":"10.1124\/jpet.105.094367_bib10","doi-asserted-by":"crossref","unstructured":"Gonzalez FJ, Schmid BJ, Umeno M, McBride OW, Hardwick JP, Meyer UA, Gelboin HV, and Idle JR (1988) Human P450PCN1: sequence, chromosome localization and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA 7: 79\u201386.","DOI":"10.1089\/dna.1988.7.79"},{"key":"10.1124\/jpet.105.094367_bib11","doi-asserted-by":"crossref","unstructured":"Gorski JC, Jones DR, Haehner-Daniels BD, Hamman MA, O\u2019Mara EM Jr, and Hall SD (1998) The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. Clin Pharmacol Ther 64: 133\u2013143.","DOI":"10.1016\/S0009-9236(98)90146-1"},{"key":"10.1124\/jpet.105.094367_bib12","doi-asserted-by":"crossref","unstructured":"Granvil CP, Yu AM, Elizondo G, Akiyama TE, Cheung C, Feigenbaum L, Krausz KW, and Gonzalez FJ (2003) Expression of the human CYP3A4 gene in the small intestine of transgenic mice: in vitro metabolism and pharmacokinetics of midazolam. Drug Metab Dispos 31: 548\u2013558.","DOI":"10.1124\/dmd.31.5.548"},{"key":"10.1124\/jpet.105.094367_bib13","doi-asserted-by":"crossref","unstructured":"Greenblatt DJ, Allen MD, Harmatz JS, and Shader RI (1980) Diazepam disposition determinants. Clin Pharmacol Ther 27: 301\u2013312.","DOI":"10.1038\/clpt.1980.40"},{"key":"10.1124\/jpet.105.094367_bib14","doi-asserted-by":"crossref","unstructured":"Guengerich FP (1999) Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 39: 1\u201317.","DOI":"10.1146\/annurev.pharmtox.39.1.1"},{"key":"10.1124\/jpet.105.094367_bib15","doi-asserted-by":"crossref","unstructured":"Hana V, Silha JV, Justova V, Lacinova Z, Stepan JJ, and Murphy LJ (2004) The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance. Clin Endocrinol (Oxf) 60: 442\u2013450.","DOI":"10.1111\/j.1365-2265.2004.02000.x"},{"key":"10.1124\/jpet.105.094367_bib16","doi-asserted-by":"crossref","unstructured":"Hines RN and McCarver DG (2002) The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes. J Pharmacol Exp Ther 300: 355\u2013360.","DOI":"10.1124\/jpet.300.2.355"},{"key":"10.1124\/jpet.105.094367_bib17","unstructured":"Holloway MG, Laz EV, and Waxman DJ (2006) Co-regulation of GH-responsive, sexually dimorphic hepatic gene expression by STAT5b and HNF4\u03b1. Mol Endocrinol, in press."},{"key":"10.1124\/jpet.105.094367_bib18","doi-asserted-by":"crossref","unstructured":"Jaffe CA, Ocampo-Lim B, Guo W, Krueger K, Sugahara I, DeMott-Friberg R, Bermann M, and Barkan AL (1998) Regulatory mechanisms of growth hormone secretion are sexually dimorphic. J Clin Investig 102: 153\u2013164.","DOI":"10.1172\/JCI2908"},{"key":"10.1124\/jpet.105.094367_bib19","doi-asserted-by":"crossref","unstructured":"Jaffe CA, Turgeon DK, Lown K, Demott-Friberg R, and Watkins PB (2002) Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans. Am J Physiol 283: E1008\u2013E1015.","DOI":"10.1152\/ajpendo.00513.2001"},{"key":"10.1124\/jpet.105.094367_bib20","doi-asserted-by":"crossref","unstructured":"Jurgens G, Lange KH, Reuther LO, Rasmussen BB, Brosen K, and Christensen HR (2002) Effect of growth hormone on hepatic cytochrome P450 activity in healthy elderly men. Clin Pharmacol Ther 71: 162\u2013168.","DOI":"10.1067\/mcp.2002.121373"},{"key":"10.1124\/jpet.105.094367_bib21","doi-asserted-by":"crossref","unstructured":"Kawai M, Bandiera SM, Chang TK, and Bellward GD (2000) Growth hormone regulation and developmental expression of rat hepatic CYP3A18, CYP3A9 and CYP3A2. Biochem Pharmacol 59: 1277\u20131287.","DOI":"10.1016\/S0006-2952(00)00247-1"},{"key":"10.1124\/jpet.105.094367_bib22","doi-asserted-by":"crossref","unstructured":"Komori M, Nishio K, Kitada M, Shiramatsu K, Muroya K, Soma M, Nagashima K, and Kamataki T (1990) Fetus-specific expression of a form of cytochrome P-450 in human livers. Biochemistry 29: 4430\u20134433.","DOI":"10.1021\/bi00470a024"},{"key":"10.1124\/jpet.105.094367_bib23","doi-asserted-by":"crossref","unstructured":"Lanes R, Gunczler P, Orta N, Bosquez M, Scovino R, Dominguez L, Esaa S, and Weisinger JR (1996) Changes in bone mineral density, growth velocity and renal function of prepubertal uremic children during growth hormone treatment. Horm Res 46: 263\u2013268.","DOI":"10.1159\/000185098"},{"key":"10.1124\/jpet.105.094367_bib24","doi-asserted-by":"crossref","unstructured":"Liddle C, Goodwin BJ, George J, Tapner M, and Farrell GC (1998) Separate and interactive regulation of cytochrome P450 3A4 by triiodothyronine, dexamethasone and growth hormone in cultured hepatocytes. J Clin Endocrinol Metab 83: 2411\u20132416.","DOI":"10.1210\/jc.83.7.2411"},{"key":"10.1124\/jpet.105.094367_bib25","doi-asserted-by":"crossref","unstructured":"Marcus R and Hoffman AR (1998) Growth hormone as therapy for older men and women. Annu Rev Pharmacol Toxicol 38: 45\u201361.","DOI":"10.1146\/annurev.pharmtox.38.1.45"},{"key":"10.1124\/jpet.105.094367_bib26","doi-asserted-by":"crossref","unstructured":"Mode A, Norstedt G, Simic B, Eneroth P, and Gustafsson JA (1981) Continuous infusion of growth hormone feminizes hepatic steroid metabolism in the rat. Endocrinology 108: 2103\u20132108.","DOI":"10.1210\/endo-108-6-2103"},{"key":"10.1124\/jpet.105.094367_bib27","doi-asserted-by":"crossref","unstructured":"Nagata K, Matsunaga T, Gillette J, Gelboin HV, and Gonzalez FJ (1987) Rat testosterone 7 alpha-hydroxylase: isolation, sequence and expression of cDNA and its developmental regulation and induction by 3-methylcholanthrene. J Biol Chem 262: 2787\u20132793.","DOI":"10.1016\/S0021-9258(18)61575-3"},{"key":"10.1124\/jpet.105.094367_bib28","doi-asserted-by":"crossref","unstructured":"Park SH, Liu X, Hennighausen L, Davey HW, and Waxman DJ (1999) Distinctive roles of STAT5a and STAT5b in sexual dimorphism of hepatic P450 gene expression: impact of STAT5a gene disruption. J Biol Chem 274: 7421\u20137430.","DOI":"10.1074\/jbc.274.11.7421"},{"key":"10.1124\/jpet.105.094367_bib29","doi-asserted-by":"crossref","unstructured":"Park SS, Cha SJ, Miller H, Persson AV, Coon MJ, and Gelboin HV (1982) Monoclonal antibodies to rabbit liver cytochrome P-450LM2 and cytochrome P-450LM4. Mol Pharmacol 21: 248\u2013258.","DOI":"10.1016\/S0026-895X(25)14580-X"},{"key":"10.1124\/jpet.105.094367_bib30","doi-asserted-by":"crossref","unstructured":"Parkinson A, Mudra DR, Johnson C, Dwyer A, and Carroll KM (2004) The effects of gender, age, ethnicity and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol 199: 193\u2013209.","DOI":"10.1016\/j.taap.2004.01.010"},{"key":"10.1124\/jpet.105.094367_bib31","doi-asserted-by":"crossref","unstructured":"Powell DR, Liu F, Baker BK, Hintz RL, Lee PD, Durham SK, Brewer ED, Frane JW, Watkins SL, and Hogg RJ (1997) Modulation of growth factors by growth hormone in children with chronic renal failure: the Southwest Pediatric Nephrology Study Group. Kidney Int 51: 1970\u20131979.","DOI":"10.1038\/ki.1997.268"},{"key":"10.1124\/jpet.105.094367_bib32","doi-asserted-by":"crossref","unstructured":"Rich KJ and Boobis AR (1997) Expression and inducibility of P450 enzymes during liver ontogeny. Microsc Res Tech 39: 424\u2013435.","DOI":"10.1002\/(SICI)1097-0029(19971201)39:5<424::AID-JEMT5>3.0.CO;2-G"},{"key":"10.1124\/jpet.105.094367_bib33","doi-asserted-by":"crossref","unstructured":"Robertson GR, Farrell GC, and Liddle C (1998) Sexually dimorphic expression of rat CYP3A9 and CYP3A18 genes is regulated by growth hormone. Biochem Biophys Res Commun 242: 57\u201360.","DOI":"10.1006\/bbrc.1997.7904"},{"key":"10.1124\/jpet.105.094367_bib34","doi-asserted-by":"crossref","unstructured":"Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, and Mattson DE (1990) Effects of human growth hormone in men over 60 years old. N Engl J Med 323: 1\u20136.","DOI":"10.1056\/NEJM199007053230101"},{"key":"10.1124\/jpet.105.094367_bib35","doi-asserted-by":"crossref","unstructured":"Sakuma T, Endo Y, Mashino M, Kuroiwa M, Ohara A, Jarukamjorn K, and Nemoto N (2002) Regulation of the expression of two female-predominant CYP3A mRNAs (CYP3A41 and CYP3A44) in mouse liver by sex and growth hormones. Arch Biochem Biophys 404: 234\u2013242.","DOI":"10.1016\/S0003-9861(02)00329-6"},{"key":"10.1124\/jpet.105.094367_bib36","doi-asserted-by":"crossref","unstructured":"Schmucker DL, Woodhouse KW, Wang RK, Wynne H, James OF, McManus M, and Kremers P (1990) Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther 48: 365\u2013374.","DOI":"10.1038\/clpt.1990.164"},{"key":"10.1124\/jpet.105.094367_bib37","doi-asserted-by":"crossref","unstructured":"Shimada M, Murayama N, Yamazoe Y, Hashimoto H, Ishikawa H, and Kato R (1995) Age- and sex-related alterations of microsomal drug- and testosterone-oxidizing cytochrome P450 in Sprague-Dawley strain-derived dwarf rats. J Pharmacol Exp Ther 275: 972\u2013977.","DOI":"10.1016\/S0022-3565(25)12152-6"},{"key":"10.1124\/jpet.105.094367_bib38","doi-asserted-by":"crossref","unstructured":"Sim SC, Edwards RJ, Boobis AR, and Ingelman-Sundberg M (2005) CYP3A7 protein expression is high in a fraction of adult human livers and partially associated with the CYP3A7*1C allele. Pharmacogenet Genomics 15: 625\u2013631.","DOI":"10.1097\/01.fpc.0000171516.84139.89"},{"key":"10.1124\/jpet.105.094367_bib39","doi-asserted-by":"crossref","unstructured":"Stevens JC, Hines RN, Gu C, Koukouritaki SB, Manro JR, Tandler PJ, and Zaya MJ (2003) Developmental expression of the major human hepatic CYP3A enzymes. J Pharmacol Exp Ther 307: 573\u2013582.","DOI":"10.1124\/jpet.103.054841"},{"key":"10.1124\/jpet.105.094367_bib40","doi-asserted-by":"crossref","unstructured":"Tirona RG, Lee W, Leake BF, Lan LB, Cline CB, Lamba V, Parviz F, Duncan SA, Inoue Y, Gonzalez FJ, et al. (2003) The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4. Nat Med 9: 220\u2013224.","DOI":"10.1038\/nm815"},{"key":"10.1124\/jpet.105.094367_bib41","doi-asserted-by":"crossref","unstructured":"van den Berg G, Veldhuis JD, Frolich M, and Roelfsema F (1996) An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab 81: 2460\u20132467.","DOI":"10.1210\/jcem.81.7.8675561"},{"key":"10.1124\/jpet.105.094367_bib42","doi-asserted-by":"crossref","unstructured":"Watkins PB, Murray SA, Winkelman LG, Heuman DM, Wrighton SA, and Guzelian PS (1989) Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450: studies in rats and patients. J Clin Investig 83: 688\u2013697.","DOI":"10.1172\/JCI113933"},{"key":"10.1124\/jpet.105.094367_bib43","doi-asserted-by":"crossref","unstructured":"Waxman DJ, LeBlanc GA, Morrissey JJ, Staunton J, and Lapenson DP (1988) Adult male-specific and neonatally programmed rat hepatic P-450 forms RLM2 and 2a are not dependent on pulsatile plasma growth hormone for expression. J Biol Chem 263: 11396\u201311406.","DOI":"10.1016\/S0021-9258(18)37970-5"},{"key":"10.1124\/jpet.105.094367_bib44","doi-asserted-by":"crossref","unstructured":"Waxman DJ, Pampori NA, Ram PA, Agrawal AK, and Shapiro BH (1991) Interpulse interval in circulating growth hormone patterns regulates sexually dimorphic expression of hepatic cytochrome P450. Proc Natl Acad Sci USA 88: 6868\u20136872.","DOI":"10.1073\/pnas.88.15.6868"},{"key":"10.1124\/jpet.105.094367_bib45","doi-asserted-by":"crossref","unstructured":"Willson TM and Kliewer SA (2002) PXR, CAR and drug metabolism. Nat Rev Drug Discov 1: 259\u2013266.","DOI":"10.1038\/nrd753"},{"key":"10.1124\/jpet.105.094367_bib46","doi-asserted-by":"crossref","unstructured":"Wiwi CA, Gupte M, and Waxman DJ (2004) Sexually dimorphic P450 gene expression in liver-specific hepatocyte nuclear factor 4alpha-deficient mice. Mol Endocrinol 18: 1975\u20131987.","DOI":"10.1210\/me.2004-0129"},{"key":"10.1124\/jpet.105.094367_bib47","doi-asserted-by":"crossref","unstructured":"Wolbold R, Klein K, Burk O, Nussler AK, Neuhaus P, Eichelbaum M, Schwab M, and Zanger UM (2003) Sex is a major determinant of CYP3A4 expression in human liver. Hepatology 38: 978\u2013988.","DOI":"10.1002\/hep.1840380424"},{"key":"10.1124\/jpet.105.094367_bib48","doi-asserted-by":"crossref","unstructured":"Yamano S, Nhamburo PT, Aoyama T, Meyer UA, Inaba T, Kalow W, Gelboin HV, McBride OW, and Gonzalez FJ (1989) cDNA cloning and sequence and cDNA-directed expression of human P450 IIB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver. Biochemistry 28: 7340\u20137348.","DOI":"10.1021\/bi00444a029"},{"key":"10.1124\/jpet.105.094367_bib49","doi-asserted-by":"crossref","unstructured":"Yu AM, Fukamachi K, Krausz KW, Cheung C, and Gonzalez FJ (2005) Potential role for human cytochrome P450 3A4 in estradiol homeostasis. Endocrinology 146: 2911\u20132919.","DOI":"10.1210\/en.2004-1248"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524325595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524325595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.105.094367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:47:52Z","timestamp":1740001672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524325595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0022356524325595"],"URL":"https:\/\/doi.org\/10.1124\/jpet.105.094367","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth Hormone Determines Sexual Dimorphism of Hepatic Cytochrome P450 3A4 Expression in Transgenic Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.105.094367","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}